Company / Profit Margin
MAXCYTE, INC. Profit Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-135.1%
FY2025
5-year range
-135.1% / -53.3%
FY2021-FY2025
Trend
-47.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -53.3% to -135.1% over the past 2 years.
Based on SEC 10-K filings.
-135.1% in FY2025 with a 3-year CAGR of -81.9%.
Declined from -53.3% to -135.1% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -81.9pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 47.1% year-over-year.
- Peak profit margin was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -135.1% | -47.1% |
| FY2024 | -91.8% | -72.5% |
| FY2023 | -53.3% | +0.0% |
| FY2022 | -53.3% | +5.4% |
| FY2021 | -56.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026